Colleen Delaney
@colleendelaney
Executive Officer
Building Nohla Therapeutics Inc. as Executive Officer
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Nohla Therapeutics Inc. was founded in 2015 and has no closure on record.
Named alongside
At Coeptis Therapeutics Holdings, Inc.
- Brian CogleyExecutive Officer
- Christine SheehyExecutive Officer
- Christopher CaliseDirector
- Christopher CochranDirector
- Christopher Maria CochranDirector
- Daniel YeraceExecutive Officer, Director
- David MehalickExecutive Officer, Director
- Gene Maria SalkindDirector
- Colleen W DelaneyExecutive Officer
- Michael W YurkowskyExecutive Officer, Director
- Michael YurkowskyExecutive Officer
- Benjamin Scot BergoExecutive Officer, Director, Promoter
- Brian DanielsDirector
- Darren David ScottiExecutive Officer
- Darren ScottiExecutive Officer
- Gary ChristiansonExecutive Officer
- Ian David BrownDirector
- Jim JohnsonExecutive Officer
- Kathleen FanningExecutive Officer, Director
At Vicapsys Life Sciences, Inc.
- Charles H. FarraharExecutive Officer
- Charlie FarraharDirector
- Dorothy J. JordanDirector
- Dorothy JordanDirector
- Federico H. PierDirector
- Federico PierChief Executive Officer
- Jeffrey WrightChief Financial Officer
- John T. Potts, Jr.Director
Contribution
Colleen's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Nohla Therapeutics Inc.Executive Officer · Biotechnology · SEATTLE, United States · Founded 2015
- Deverra Therapeutics, Inc.Executive Officer · Biotechnology · SEATTLE, United States · Founded 2019
- Vicapsys Life Sciences, Inc.Pharmaceutical Preparations; formerly SSGI, INC.; filing with the SEC since 2009Director · Biotechnology · CUMMING, United States
- Coeptis Therapeutics Holdings, Inc.Finance Services; formerly Coeptis Therapeutics Holdings, Inc.; listed on Nasdaq as ZSQR; filing with the SEC since 2019Executive Officer · Pharmaceuticals · WEXFORD, United States · Founded 2022